Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251840 | 0.77 | HSD11B1 (0.50) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL12714 | 0.74 | HSD11B1 (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL133056 | 0.74 | HSD11B1 (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL19557166 | 0.74 | HSD11B1 (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL19557168 | 0.74 | HSD11B1 (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| Ammonia Solution, Strong SCHEMBL11787415 | 0.74 | HSD11B1 (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL546352 | 0.74 | HTT (0.48) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL3843956 | 0.74 | HSD11B1 (0.44) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL13085219 | 0.72 | HSD11B1 (0.46) | HSD11B1L3MBTL1EPHX1EPHX2HTT | |
| SCHEMBL5489940 | 0.72 | HSD11B1 (0.46) | HSD11B1L3MBTL1EPHX1EPHX2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903112-A | Sulfur-containing deoxidized fluoridation reagent and preparation method and application thereof | 铜陵学院 | 2024-04-19 | — | — | CN | disclosed |
| CN-112174761-B | Fluorination method | 三明市海斯福化工有限责任公司 | 2023-03-24 | — | — | CN | disclosed |
| US-20210155561-A1 | METHOD AND REAGENT FOR DEOXYFLUORINATION | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-05-27 | — | — | US | disclosed |
| US-8173297-B2 | Improved high-temperature storage and cycle characteristics; succinyl chloride or succinyl fluoride as solvent; computers | SONY CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| CN-101132083-B | Electrolytic solution and battery | SONY CORP | 2010-12-15 | — | — | CN | disclosed |
| US-20080076031-A1 | ELECTROLYTIC SOLUTION AND BATTERY | SONY CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| CN-101132083-A | Electrolytic solution and battery | SONY CORP (JP) | 2008-02-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210155561-A1 | METHOD AND REAGENT FOR DEOXYFLUORINATION | PFAS, FIBP, NPFFR2 | HSD11B1 2724/4885L3MBTL1 4692/4885EPHX1 2891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.